Pramlintide
Links shared publicly online about this topic
Diabetes Drugs: Pramlintide :: Diabetes Self-Management
diabetesselfmanagement.com — “Many people do not think of the brain when considering the causes of or treatments for diabetes. so it may be surprising to learn that the drug we are discussing today works by activating brain cells...” View full resource at diabetesselfmanagement.com
Most Recently Shared on September 25, 2009 at 8:51 pm By:
Diabetes Self-Mgmt Health Site
#diabetes Learn the particulars about pramlintide in the eighth installment of Mark Marino's series on diabetes drugs. http://bit.ly/YABdu
Closed Loop System With Pramlintide Versus Exenatide - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Closed Loop System With Pramlintide Versus Exenatide - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on August 20, 2011 at 2:02 am By:
Clinical Trial NYC Closed Loop System With Pramlintide Versus Exenatide (Closedloop) http://t.co/iK8m0le #diabetes
Amylin Pharmaceuticals and Takeda Pharmaceutical to advance pramlintide/metreleptin combination therapy development
news-medical.net — “Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced today that the companies have selected the combination treatment of pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin, for advancement toward Phase 3 development. The decision to advance the program followed encouraging results from a 52-week blinded, placebo-controlled Phase 2 extension study. The pramlintide/metreleptin combination met the key target cri” View full resource at news-medical.net
Most Recently Shared on February 23, 2010 at 10:12 am By:
Obesity News: Amylin Pharmaceuticals and Takeda Pharmaceutical to advance pramlintide/metreleptin combination th... http://twurl.nl/viyedg
The Role of Pramlintide for Weight Loss (March) -- Dunican et al., 10.1345/aph.1M210 -- The Annals of Pharmacotherapy
theannals.com — “The Role of Pramlintide for Weight Loss (March) -- Dunican et al., 10.1345/aph.1M210 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on February 18, 2010 at 3:27 am By:
The Role of Pramlintide for Weight Loss (March): OBJECTIVE: To evaluate the weight-loss effects of pr... http://bit.ly/byHnz9
Amylin Pharmaceuticals Announces Positive Results From Dose-Ranging Clinical Study Of Pramlintide/Metreleptin Combination Treatment For Obesity
medicalnewstoday.com — “Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced positive results from a 28-week dose-ranging study of pramlintide/metreleptin, a combination treatment comprising pramlintide, an analog of t” View full resource at medicalnewstoday.com
Most Recently Shared on July 10, 2009 at 6:37 pm By:
James Beckerman, MD Physician, Doctor, Internist, and Cardiologist
Intriguing developments from Amylin for treatment of #obesity - about 18 pounds in seven months. http://tinyurl.com/l7qrs4 #weightloss
Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program - Drugs.com MedNews
drugs.com — “Collaboration Will Explore Potential of Other Assets to Address Obesity Epidemic OSAKA, Japan, Aug. 5, Amylin Pharmaceuticals, Inc. (Nasdaq AMLN) and Takeda Pha” View full resource at drugs.com
Most Recently Shared on August 5, 2011 at 1:06 pm By:
Drugs and Devices OW OW Health
Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Fol... http://bit.ly/p1ft6q #drug
MedWire News - Diabetes - Pramlintide modestly lowers HbA1c, weight in Type 2 diabetes patients
medwire-news.md — “MedWire News Results from a systematic review and meta-analysis show that pramlintide, a synthetic amylin analog, is modestly effective for reducing glycated hemoglobin and weight in Type 2 diabetic or obese patients. MedWire News” View full resource at medwire-news.md
Most Recently Shared on November 25, 2010 at 2:37 pm By:
Pramlintide modestly lowers HbA1c, weight in Type 2 diabetes patients: Results from a systematic review and meta... http://bit.ly/fm84rs
Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program - Health News - redOrbit
redorbit.com — “SAN DIEGO, Aug. 4, 2011 /PRNewswire/ -- OSAKA, Japan, Aug. 5, 2011 -- Amylin Pharmaceuticals, Inc.” View full resource at redorbit.com
Most Recently Shared on August 5, 2011 at 4:53 am By:
Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following... http://bit.ly/pnUdb1
Amylin Pharmaceuticals To Present New Data And Insights From The Company's Diabetes Programs At ADA 2010
medicalnewstoday.com — “Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced that the Company will present data for its FDA-approved diabetes drugs, BYETTA® (exenatide) injection and SYMLIN® (pramlintide acetate” View full resource at medicalnewstoday.com
Most Recently Shared on June 19, 2010 at 2:04 pm By:
Amylin Pharmaceuticals To Present New Data And Insights From The Company's Diabetes Programs At ADA 2010 http://mnt.to/3F6w #diabetes
Obesity Trial of Drug Pair Halted | ThirdAge
thirdage.com — “An obesity trial using two drugs, pramlintide and metreleptin was halted this week by the makers of the drugs.” View full resource at thirdage.com
Most Recently Shared on August 6, 2011 at 5:27 pm By:
Obesity Trial of Drug Pair Halted http://bit.ly/qCs4IT
Endocrinology Article | Diabetes Mellitus
mdlinx.com — “Efficacy and Harms of the Hypoglycemic Agent Pramlintide in Diabetes Mellitus” View full resource at mdlinx.com
Most Recently Shared on November 16, 2010 at 12:11 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy and Harms of the Hypoglycemic Agent Pramlintide in Diabetes Mellitus: Annals of Family Medicine http://bit.ly/9irKlV #endo
Endocrinology Article | Glucose
mdlinx.com — “Use of continuous glucose monitoring to introduce adjunctive pramlintide therapy in a patient with type 1 diabetes: A case study” View full resource at mdlinx.com
Most Recently Shared on July 25, 2011 at 8:04 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Use of continuous glucose monitoring to introduce adjunctive pramlintide therapy in a patient with type 1 ... http://bit.ly/rfQ3AA #endo
Amylin And Takeda Discontinue Development Of
pharmaceuticalonline.com — “Amylin And Takeda Discontinue Development Of Pramlintide/Metreleptin Combination Treatment For Obesity Following Commercial Reassessment Of The Program - Amylin Pharmaceuticals” View full resource at pharmaceuticalonline.com
Most Recently Shared on August 8, 2011 at 5:22 pm By:
Amylin And Takeda Discontinue Development Of Pramlintide/Metreleptin Combination Treatment For Obesity Following... http://bit.ly/qIIhxi
Researchers seek to determine if combination of two type 1 diabetes medications will work
endocrineweb.com — “A new study on the possibility of combining injections of insulin and the blood sugar-mediating drug pramlintide could help individuals with type 1 diabetes limit the number of injections they need to take each day.Currently, pramlintide is not approved for use in combination with insulin.” View full resource at endocrineweb.com
Most Recently Shared on May 12, 2011 at 11:17 am By:
Researchers seek to determine if combination of two type 1 diabetes medications will work http://dlvr.it/RSPd8
Researchers seek to determine if combination of two type 1 diabetes medications will work
endocrineweb.com — “A new study on the possibility of combining injections of insulin and the blood sugar-mediating drug pramlintide could help individuals with type 1 diabetes limit the number of injections they need to take each day.Currently, pramlintide is not approved for use in combination with insulin.” View full resource at endocrineweb.com
Most Recently Shared on May 11, 2011 at 11:40 pm By:
Researchers seek to determine if combination of two type 1 diabetes medications will work: A new study on the po... http://bit.ly/lU9KG0
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Diabetes Self-Mgmt
-
Ellen H Ullman
MSW, Activities Director @DayscapeFL, Dedicated to a cure for type 1 diabetes,VP @cwdfoundation,PEP Squad @diabetes_dri, quintessentially resourceful
-
News-Medical.Net
Stay up to date with the latest Obesity news and research via News-Medical.Net
Advertisement
